Bayer, Merck KGaA spend big bucks for market share in China

Carly Helfand Multinational pharma companies have been targeting China for years with an eye on its aging population, expanding middle class and growing incidence of chronic maladies ...

Merck and Roche prep breast cancer data for promising PD-1 drugs

Emily Mullin As fervor surrounding a new class of cancer drugs builds, drug giants Merck and Roche are set to roll out new data for their opposing immunotherapy drugs for breast cancer ...

Merck taps celeb chef to deliver diabetes message to Hispanics

Carly Helfand Merck's America's Diabetes Challenge: Get to Your Goals campaign is aimed at persuading patients to do what it takes to keep their blood sugar in check. Now, Merck ...

Pfizer, Merck, pick up hefty vax sales bump with CDC nod in seniors

Carly Helfand Pfizer's Prevnar 13, the world's best-selling vaccine, scored a big win Wednesday, nabbing a CDC committee nod for universal use in adults over the age of 65. ...

Merck spokeswoman: Sales layoffs to hit PA-based field reps

Tracy Staton The job-cutting ax has come out for Merck's U.S. field force, as part of a move to cut 600 positions by August.  FiercePharma News

Merck whacks 600 sales reps as part of 8,500 bloodletting

Eric Palmer Merck is going through a complete makeover, buying and selling units at a rapid pace. And some of its employees are getting caught in its "out with the old and in with ...

Gilead litigation says claims by Merck, AbbVie on Sovaldi are patently wrong

Eric Palmer Gilead Sciences got to the market first with an interferon-free oral hepatitis C fighter, a category projected to hit $ 20 billion in sales by 2020. Its Sovaldi has been ...

Merck KGaA brings on U.S. Merck’s Rossetti to head R&D

Michael Gibney FierceBiotech News

Merck attacks Italian critic of cholesterol fighter Zetia, then backs off

Arlene Weintraub In February and again in May, Merck sent a cease-and-desist order to Alberto Donzelli, head of education, appropriateness, and evidence-based medicine at Milan's ...

Merck vet steps in to lead Third Rock’s immuno-oncology upstart

John Carroll FierceBiotech News

Bayer likes all the brands it got from Merck, Coppertone and Dr. Scholl’s included

Carly Helfand Should Bayer sell some of the consumer brands it's buying from Merck in a $ 14 billion deal? Analysts say a few of them–Coppertone sun products, for instance–don't ...

Novartis nabs Merck exec Bruno Strigini to head up oncology business

Tracy Staton Novartis wooed one of Merck & Co.'s top executives to take the helm at its oncology unit. FiercePharma News
Page 3 of 1112345...10...Last »
© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS